Janus 10-Q Details $18.3M Impairment and $30M Debt Paydown Behind Q3 Loss
JBI is trading near its 52-week low of $3.575 (9.1% above the low) on elevated volume (3.0× avg).
Summary
Janus's Q3 10-Q confirms the $13.3M net loss and guidance cut already reported, and adds $18.3M of non-cash impairment plus a $30.0M voluntary debt prepayment that pulled cash down to $99.9M.
Key Events · Earnings and Guidance · JBI
-
Q3 Loss and Guidance Cut Confirmed
Net loss of $13.3M, or $(0.10) per diluted share, on revenue of $213.1M, down 2.8% year over year; full-year 2026 revenue guidance cut to $855-$865M from $925-$945M.
-
$18.3M Non-Cash Impairment Booked
Goodwill impairment of $5.0M at BETCO and $7.4M at Kiwi II, plus $5.9M on the DBCI and ACT tradenames; the ACT tradename now carries zero value.
-
$30M Debt Prepayment Drains Cash
Voluntary prepayment of $30.0M on the First Lien Term Loan left cash at $99.9M versus $194.4M at January 3, 2026; $73.8M remains available on the revolver.
-
Kiwi II Acquisition Still Loss-Making
The January 8, 2026 acquisition for $98.9M contributed $10.7M of Q3 revenue but a $10.8M net loss including amortization and goodwill impairment.
Analysis · JBI · Manufacturing
The headline numbers — a $13.3M net loss and a cut to $855-$865M revenue guidance — were already out via this morning's 8-K and press release. What the 10-Q adds is the balance-sheet damage: $18.3M of non-cash impairment split between BETCO ($5.0M) and Kiwi II ($7.4M) goodwill plus $5.9M on the DBCI and ACT tradenames, and a $30.0M voluntary prepayment on the First Lien Term Loan that helped drain cash to $99.9M from $194.4M at the start of the year. The Kiwi II deal, closed January 8 for $98.9M, is already producing a $10.8M quarterly net loss including amortization and impairment — the acquisition is not covering its cost of capital. Management is offsetting this with buybacks ($25.3M in Q3, $38.1M left) and debt paydown, but with organic revenue down 7.7% in the quarter and Adjusted EBITDA off 22.0% to $34.0M, the capital return is being funded from a shrinking cash pile.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 47.7% of the 1624 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JBI was trading at $3.90 on NYSE in the Manufacturing sector, with a market capitalization of approximately $533.5M. The 52-week trading range was $3.58 to $7.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.